FTO‐mediated m 6 A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer
Clinical and Translational Medicine · 2025-07 · 15 (7)
DOI: 10.1002/ctm2.70392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 07.07.2025. Verfasst von Haiyang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Tongji Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Lung Neoplasms, Insulin-Like Growth Factor Binding Protein 3, RNA-Binding Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Industry-university Cooperative education program of Ministry of Education, Shanghai Oriental Talent Program top project.
Abstract (Originalsprache)
Lung cancer remains one of the leading causes of cancer‐related deaths worldwide, and a growing body of evidence suggests that RNA modifications, including methylation, play a critical role in its progression. In this study, we investigated the role of the RNA demethylase fat mass and obesity‐associated protein (FTO) in lung cancer progression and determined the underlying molecular mechanisms. FTO expression was significantly upregulated in LUAD and correlated with poor prognosis. FTO knockdown in lung patient‐derived organoids and LUAD cell lines reduced their proliferation, invasion, and migration, and FTO knockdown in a Kras G12D mouse model reduced the growth of lung tumours. Mechanistically, FTO demethylated m 6 A sites in the insulin‐like growth factor‐binding protein 3 (IGFBP3) 3′UTR, preventing IMP3 binding. The ribonuclear protein IMP3 was identified as a crucial functional reader that interacted with m 6 A‐modified sites in the IGFBP3 3′UTR, thereby promoting IGFBP3 mRNA localisation to P‐bodies and suppressing its translation. Elevated IGFBP3 activated AKT signalling and promoted tumour progression. Collectively, we revealed that FTO drives lung cancer progression via m 6 A‐dependent sequestration of IGFBP3 mRNA into P‐bodies by IMP3, which suppresses translation and activates AKT signalling. The FTO–IGFBP3–AKT axis thus represents a promising therapeutic target. Key points FTO regulates the translation of IGFBP3 by demethylating m6A sites in the 3′‐untranslated region of IGFBP3 mRNA. Binding of the m6A reader protein IMP3 to 3′UTR m6A sites in IGFBP3 mRNA promoted its localisation and sequestration in cellular organelles known as to P‐bodies, thereby suppressing IGFBP3 mRNA translation. IGFBP3 regulates activation of the AKT signalling pathway, and that FTO‐mediated regulation of IGFBP3 influences LUAD malignant behaviours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Tongji Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China.
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), Shanghai, China.
- Department of Thoracic and Cardiovascular Surgery, Tongji Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Haiyang Wang, Yongxin Zhou
Förderung
- National Natural Science Foundation of China
- Industry-university Cooperative education program of Ministry of Education
- Shanghai Oriental Talent Program top project
Zitieren
APA
Wang, H., Peng, H., Zhang, Z., Abulimiti, Y., Hu, J., Zhou, Y., Ji, P., & Li, D. (2025). FTO‐mediated m 6 A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer. Clinical and Translational Medicine, 15(7). https://doi.org/10.1002/ctm2.70392
Vancouver
Wang H, Peng H, Zhang Z, Abulimiti Y, Hu J, Zhou Y, et al. FTO‐mediated m 6 A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer. Clinical and Translational Medicine. 2025;15(7). doi:10.1002/ctm2.70392
BibTeX
@article{Wang2025,
author = {Wang, Haiyang and Peng, Hui and Zhang, Zhenzhen and Abulimiti, Yilimunuer and Hu, Jiayi and Zhou, Yongxin and Ji, Ping and Li, Dong},
title = {FTO‐mediated m 6 A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {7},
doi = {10.1002/ctm2.70392}
}
EUVIMED